BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17601993)

  • 1. Inhibition of lipolysis stimulates peripheral glucose uptake but has no effect on endogenous glucose production in HIV lipodystrophy.
    Lindegaard B; Frøsig C; Petersen AM; Plomgaard P; Ditlevsen S; Mittendorfer B; Van Hall G; Wojtaszewski JF; Pedersen BK
    Diabetes; 2007 Aug; 56(8):2070-7. PubMed ID: 17601993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
    Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
    Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy.
    Haugaard SB; Andersen O; Madsbad S; Frøsig C; Iversen J; Nielsen JO; Wojtaszewski JF
    Diabetes; 2005 Dec; 54(12):3474-83. PubMed ID: 16306364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
    Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
    Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
    Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
    J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.
    Bajaj M; Suraamornkul S; Kashyap S; Cusi K; Mandarino L; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4649-55. PubMed ID: 15356076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia.
    Hadigan C; Liebau J; Torriani M; Andersen R; Grinspoon S
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4438-44. PubMed ID: 16940448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution.
    Hadigan C; Rabe J; Meininger G; Aliabadi N; Breu J; Grinspoon S
    Am J Clin Nutr; 2003 Feb; 77(2):490-4. PubMed ID: 12540412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans.
    Gormsen LC; Jessen N; Gjedsted J; Gjedde S; Nørrelund H; Lund S; Christiansen JS; Nielsen S; Schmitz O; Møller N
    J Clin Endocrinol Metab; 2007 May; 92(5):1834-42. PubMed ID: 17341555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.
    Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5813-8. PubMed ID: 11739444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy.
    Haugaard SB; Andersen O; Pedersen SB; Dela F; Fenger M; Richelsen B; Madsbad S; Iversen J
    Metabolism; 2006 Feb; 55(2):175-82. PubMed ID: 16423623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy.
    Blümer RM; van der Valk M; Ackermans M; Endert E; Serlie MJ; Reiss P; Sauerwein HP
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1097-104. PubMed ID: 19690066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
    Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
    Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute reduction of lipolysis reduces adiponectin and IL-18: evidence from an intervention study with acipimox and insulin.
    Lindegaard B; Ditlevsen S; Plomgaard P; Mittendorfer B; Pedersen BK
    Diabetologia; 2013 Sep; 56(9):2034-43. PubMed ID: 23811808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
    Santomauro AT; Boden G; Silva ME; Rocha DM; Santos RF; Ursich MJ; Strassmann PG; Wajchenberg BL
    Diabetes; 1999 Sep; 48(9):1836-41. PubMed ID: 10480616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markedly diminished lipolysis and partial restoration of glucose metabolism, without changes in fat distribution after extended discontinuation of protease inhibitors in severe lipodystrophic human immunodeficient virus-1-infected patients.
    van der Valk M; Allick G; Weverling GJ; Romijn JA; Ackermans MT; Lange JM; van Eck-Smit BL; van Kuijk C; Endert E; Sauerwein HP; Reiss P
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3554-60. PubMed ID: 15240645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial.
    Makimura H; Stanley TL; Suresh C; De Sousa-Coelho AL; Frontera WR; Syu S; Braun LR; Looby SE; Feldpausch MN; Torriani M; Lee H; Patti ME; Grinspoon SK
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1123-33. PubMed ID: 26691888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.